Sterling Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Sterling Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.58M	Sell	282,750 -168,242	-37%	-$5.6M	0.16%	137
2026 Q1	$13.6M	Sell	450,992 -408,196	-48%	-$13.1M	0.26%	74
2025 Q4	$26.8M	Sell	859,188 -642,473	-43%	-$15.8M	0.44%	53
2025 Q3	$30.3M	Buy	1,501,661 +13,689	+0.9%	+$240K	0.44%	50
2025 Q2	$24.9M	Sell	1,487,972 -552,263	-27%	-$8.91M	0.35%	55
2025 Q1	$31.4M	Sell	2,040,235 -31,618	-2%	-$565K	0.49%	45
2024 Q4	$45.7M	Sell	2,071,853 -237,189	-10%	-$4.32M	0.63%	41
2024 Q3	$41.6M	Buy	+2,309,042	New	+$40.4M	0.54%	39
2019 Q3	$858K	Buy	+124,675	New	+$955K	0.01%	682
2018 Q4	–	Sell	-38,050	Closed	-$820K	–	923
2018 Q3	$820K	Hold	38,050	–	–	0.01%	711
2018 Q2	$925K	Buy	+38,050	New	+$776K	0.01%	640
2017 Q4	–	Sell	-14,900	Closed	-$263K	–	953
2017 Q3	$263K	Buy	+14,900	New	+$335K	﹤0.01%	842
2016 Q1	–	Sell	-8,047	Closed	-$529K	–	986
2015 Q4	$529K	Buy	+8,047	New	+$497K	﹤0.01%	725
2014 Q4	–	Sell	-3,872	Closed	-$208K	–	960
2014 Q3	$208K	Sell	3,872 -6,901	-64%	-$366K	﹤0.01%	872
2014 Q2	$564K	Buy	+10,773	New	+$551K	﹤0.01%	703
2014 Q1	–	Sell	-1,397,887	Closed	-$56M	–	963
2013 Q4	$56M	Sell	1,397,887 -245,725	-15%	-$9.68M	0.51%	82
2013 Q3	$62.1M	Sell	1,643,612 -29,365	-2%	-$1.15M	0.73%	59
2013 Q2	$65.6M	Buy	+1,672,977	New	+$65.2M	0.81%	48

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Sterling Capital Management's TEVA Position: Q2 2026 in Review

Sterling Capital Management reduced its Teva Pharmaceuticals (TEVA) stake by 37% in Q2 2026, selling an estimated $5.6M and leaving 282,750 shares worth $9.58M. The position accounts for 0.16% of the portfolio, ranked #137.

Sterling Capital Management first reported a position in TEVA in Q2 2013 and has held it in 18 quarters since. The position peaked at $65.6M in Q2 2013. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Sterling Capital Management held 282,750 shares of Teva Pharmaceuticals worth $9.58M as of Q2 2026.
Sterling Capital Management sold 168,242 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.6M.
Teva Pharmaceuticals made up 0.16% of Sterling Capital Management's portfolio in Q2 2026, its #137 holding.
Sterling Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
Sterling Capital Management's Teva Pharmaceuticals position peaked at $65.6M in Q2 2013.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.